Pierre Soubeyran BRIO’s director
Pierre Soubeyran, Director BRIO, is Professor of Universities (University of Bordeaux) and Specialist Doctor of Centers for the Fight against Cancer at the Bergonié Institute in Bordeaux (Department of Medical Oncology). He obtained his Doctorate in Medicine in 1989, his Diploma of Special Studies in 1989 and his PhD in Biology and Medical Sciences (Option: Biology – Health) in 1996. His interests are non-Hodgkin’s lymphoma, biology molecular and oncogeriatrics.
Since 2013, he has been Director of BRIO (Bordeaux Integrated Research in Oncology), Director of the ACTION (Actions for Oncogenesis Understanding and Target Identification in Oncology) team at Inserm since 2016. He is also Director of Research at the Institut Bergonié.
He is a member of several scholarly societies, including: American Society of Clinical Oncology (ASCO, since 2001), American Society of Hematology (ASH, since 1993), European Society of Medical Oncology (ESMO, since 1990), European Society of Therapeutic Radiology and Oncology (ESTRO, since 1987), International Society of Geriatric Oncology (SIOG, since 2002).
He also has several scientific responsibilities: he is a member of the Scientific Steering Committee of the Cancéropôle du Grand Sud-Ouest, since 2007, member of the Strategic Committee and the Technical Committee of the Data Processing Center (CTD) Clinical Trials in Cancerology of Bordeaux, labeled by the National Cancer Institute. Co-coordinator of the Oncogeriatrics Coordination Unit (UCOG), accredited by the National Cancer Institute. Co-coordinator of the Regional Thematic Groups “Hematologic Hematology” and “Oncogeriatrics” of the Aquitaine Cancer Network. Member of the Committee for Research in Biomedical and Public Health (CRBS) of the University Hospital of Bordeaux. Member of national or European expert committees for different oncogeriatric pharmaceutical laboratories (Chugai, Roche, Celgene, AMGEN).
Pr Alain Ravaud BRIO assistant director
Alain Ravaud is a medical oncologist at the University Hospital of Bordeaux and professor of oncology at the University of Bordeaux. He is a member of Inserm Unit 1029 (Director Pr Andreas Bikfalvi). He is the medical director of the 3C Bordeaux University Hospital and coordinated the Integrated Cancer Center at Bordeaux University Hospital. He coordinates at the regional level the DES of oncology and represents at the national level the coordination of the FST in oncology.
He did his internship in Toulouse from 1982 to 1988, graduated as a doctor of medicine in 1988, served as a CCA and then as a practitioner of centers at the Institut Bergonié from 1988 to 2002 before being appointed professor of oncology at the University Hospital of Bordeaux.
These areas of interest are mainly kidney cancer, bladder cancer and early stages. Most publications (Pub Med: 260) deal with these topics.
He is a reviewer for international journals including rank A.
He is a member of cooperative groups (GETUG: urological tumors) and learned societies (ASCO, ESMO). He is a member of the editors of the ESMO recommendations on bladder tumors.
Pr Simone Mathoulin-Pélissier BRIO assistant director
Simone Mathoulin-Pelissier is Professor of Public Health and Epidemiology. After studying medicine in Marseille and Bordeaux, Professor Simone Mathoulin-Pelissier continued in 1994 with a Diploma of Advanced Studies of epidemiology and public health intervention. She was appointed as a hospital practitioner Centers for the Fight Against Cancer in 2002 and obtained his habilitation research in 2006. In 2010, she became University Professor in epidemiology, health economics and prevention with a hospitable valence Bergonié Institute. It is now the Medical Coordinator in the Department of Clinical Research and Innovation (DRCI), medical officer of the axis for Cancer Investigation Center Clinic (CIC1401) and head of the research unit Clinical epidemiology (UREC) which manages the esssais external promoters but also the tests developed by Institut Bergonié (methodological support, biostatistics).
She teaches at the University of Bordeaux on the topic of cancer epidemiology as evaluation of health activities and is one of several scientific societies (the Board) as the Association of French-speaking Epidemiologists (ADELF ), the French Sarcoma Group (GSF), the French Oncogeriatrics Society (SOFOG). She is also Deputy Director of the Life Science and Health Department at the University of Bordeaux and Deputy Director of SIRIC BRIO 2.
Research in epidemiology, since 2016, it has developed activities that have created the U1219 Inserm center of the epicene team (EPIdemiology Cancer and Environmental Exhibitions), of which she is the director. Her research interests include health disparities, prevention including screening, the elderly, the design of cancerology trials and the etiology of certain cancers, including rare cancers.
Dr Julie Dechanet-Merville BRIO assistant director
Julie Déchanet-Merville is Research Director at CNRS. She spent her dissertation in immunology at the University of Lyon in 1995. She studied the last stages of differentiation of B lymphocytes in the Schering-Plow laboratory for immunology research directed by Dr. Jacques Banchereau. She then worked in the field of immunology of human transplants in the team of Jean-François Moreau at the University of Bordeaux. In 1998, she was recruited as a Research Fellow at the CNRS and set up a research team specifically interested in the involvement of DC-SIGN and human gamma-delta T cells in cytomegalovirus infection. His team discovered the antiviral role of these cells against human cytomegalovirus and was a pioneer in the study of their function and antigenic specificity. Most of his studies have involved close collaborations with the Clinical Transplant Department of Bordeaux University Hospital and with national and international academic partners. Currently, she leads a CNRS research team of about 50 people and a service unit at the University of Bordeaux (TBMcore). She is developing fundamental and translational research focused on the functions of gamma-delta T cells in cancer, viral infections and organ transplants. His studies range from molecular analysis of gamma-delta T-cell antigens to the development of preclinical mouse models as well as the study of patient cohorts. She has developed technologies for T cell culture, T cell receptor (TCR) protein analysis, monoclonal antibody production and TCR antigen identification. She is involved in immunology training for students in basic science and medicine. She is an evaluator for international publications in immunology and for funding bodies for European medical research.
Nathalie Caplet Communication and mediation manager
Nathalie Caplet, Head of Mediation and Scientific Communication BRIO, is in charge of setting up, coordinating and monitoring the program of dissemination of scientific knowledge in collaboration with other SIRIC members and partners.
Graduated from the University of Bordeaux, she is pursuing a thesis in molecular microbiology in Bristol, UK, where she begins to undertake various projects in the field of communication / scientific culture. She is then engaged as a journalist for an international B2B journal of the veterinary industry. Back in France, she started at Cap Sciences, the Center for Scientific and Technical Culture of Bordeaux, as editor and editor. She then held various positions at Cap Sciences: communication, international relations, responsible for scientific resources, organization and animation of events … In parallel, she has a freelance activity, mainly writing articles for the veterinary industry among others.
She is committed to BRIO in March 2016. Her job is to communicate internally and externally to researchers, doctors, patients and the general public and to create a link between them. She has developed and accompanies the community ASPERON & CO (Associations and Patients Engaged for Research in Oncology & Professional Community). This group of patients, former patients, caregivers, association volunteers, health professionals and researchers, imagine and carry out projects to create a link between patients and research mainly by improving collaboration and communication.
Christelle Liard Project Manager
Christelle Liard is a project manager within SIRIC BRIO whose mission is to monitor the operational and scientific aspects of research programs. She is also in charge of partnerships for BRIO in connection with pharmaceutical companies and academic research centers in French oncology.
First graduated from ESBS in 2007 (School of Biotechnology of Strasbourg, Basel and Friborg), Christelle obtained in 2010 a doctorate in immunology at the University Pierre and Marie Curie (Paris VI). Recruited as head of the pharmacology department for the INVECTYS start-up, she participates in the development of immunotherapeutic products against cancer. She filed four European and American patents before joining the pharmaceutical industry, first as national medical officer in transplantation at Novartis. She then joined the Bristol-Meyers Squibb France group as medical officer “early assets and emerging tumors” where she coordinates the implementation of early clinical phases in France for new cancer immunotherapy molecules.
Since October 2018, Christelle now works to coordinate the various research programs of SIRIC BRIO while getting involved in the Oncosphère Bordeaux project for which she sets up major strategies of partnerships with industry.
Lise Molimard Communication and patient involvement assistant
Lise Molimard, communication and patient involvement assistant for BRIO is in charge of her communication actions and supports her manager Nathalie Caplet on the process of involving patients in research. Former cancer patient, she is president of an association of young patients “We are here”.
During her biology studies, Lise is diagnosed with sarcoma, a soft tissue cancer, for which she will be treated for several years. The discoveries of hospital and associative circles that she made during her medical career prompted her to enroll in a master of Mediation Sciences in Bordeaux to combine its areas of interest: health and communication with the public. His meeting with the SIRIC BRIO team in 2017 allowed him to take part in many actions within the ASPERON & Co collective (Associations and Patients Engaged for Research in Oncology and Professional Community) and to complete his end of study internship. to BRIO’s communications manager, Nathalie Caplet.
Since September 2019, she is committed to BRIO in the continuity of her missions and works to disseminate the knowledge produced within the scientific community, especially for the general public. It is particularly committed to promoting the involvement of patients in research.
Christopher Pomier Executive Assitant
Christopher is administrative and logistics assistant at SIRIC BRIO.
He graduated from a Professional Baccalaureate Management – Administration and wanted to continue his studies towards a BTS Accounting. After one year, he realized that this path was not intended for him, so he wanted to reorient himself towards a BTS which corresponded to him more as a result of his BAC PRO. Today, he has integrated a BTS SME Management alternately (over 2 years) and wanted to work at SIRIC BRIO to discover a new field and a new way of working.